Search results
2 dni temu · Time to sustained recovery, defined as 3 or more days without symptoms, didn't differ between the 628 and 622 participants assigned to montelukast or placebo, respectively (adjusted hazard ratio [aHR], 1.02; 95% credible interval [CrI], 0.92 to 1.12). The unadjusted median time to symptom resolution was 10 days in both groups.
9 sty 2024 · The agency’s label, which was primarily aimed at doctors, was supposed to sound an alert about the 25-year-old medication, Singulair, also known by its generic name, montelukast. But it barely...
1 maj 2024 · In a statement, published on 29 April 2024, alongside a drug safety update outlining new safety measures, the Medicines and Healthcare products Regulatory Agency (MHRA) said that “more prominent warnings” will be added to the patient information leaflet (PIL), provided with every pack of montelukast in the UK.
Montelukast, sold under the brand name Singulair among others, is a medication used in the maintenance treatment of asthma. [6] It is generally less preferred for this use than inhaled corticosteroids. [6] It is not useful for acute asthma attacks. [6] Other uses include allergic rhinitis and hives of long duration. [6]
17 lis 2023 · Co to jest i na co pomaga montelukast? Montelukast jest lekiem antyleukotrienowym. Oznacza to, że hamuje działanie receptorów leuktotrienowych, które z kolei odpowiadają za tworzenie się stanu zapalnego w organizmie.
12 sty 2024 · An article published by the New York Times outlines how an FDA black box warning for the asthma drug Singulair (montelukast) did little to alert patients to its potential mental health side effects or to dissuade physicians from prescribing it.
9 lut 2024 · In the present study, we show, for the first time, that montelukast strongly reduced the mRNA expression of Il1β and Ccl2 in the ischemic area of mice subjected to permanent LAD ligation.
